Casdin Capital’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-207,500
| Closed | -$3.84M | – | 33 |
|
|
2018
Q3 | $3.84M | Hold |
207,500
| – | – | 0.47% | 32 |
|
|
2018
Q2 | $4.74M | Hold |
207,500
| – | – | 0.66% | 27 |
|
|
2018
Q1 | $5.9M | Buy |
207,500
+30,000
| +17% | +$853K | 1.04% | 24 |
|
|
2017
Q4 | $3.75M | Hold |
177,500
| – | – | 0.91% | 22 |
|
|
2017
Q3 | $3.23M | Hold |
177,500
| – | – | 0.91% | 23 |
|
|
2017
Q2 | $2.75M | Hold |
177,500
| – | – | 1.02% | 24 |
|
|
2017
Q1 | $3.07M | Buy |
177,500
+50,000
| +39% | +$863K | 1.81% | 20 |
|
|
2016
Q4 | $1.4M | Hold |
127,500
| – | – | 1.16% | 22 |
|
|
2016
Q3 | $2M | Sell |
127,500
-106,679
| -46% | -$1.67M | 1.62% | 21 |
|
|
2016
Q2 | $2.39M | Sell |
234,179
-86,844
| -27% | -$887K | 2.38% | 15 |
|
|
2016
Q1 | $4.14M | Hold |
321,023
| – | – | 4.75% | 11 |
|
|
2015
Q4 | $6.7M | Buy |
+321,023
| New | +$6.7M | 5.92% | 4 |
|